SCHEMBL8337242

SCHEMBL8337242

CC(O)C(=O)[C@H](Cc1ccc(-c2ccccc2Oc2ccccc2)cc1)NC(=O)c1cc(Br)ccc1OC/C=C/c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ITGA4 P13612 4/20 0.36
ITGB1 P05556 3/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
PPARA Q07869 5/20 0.36
PPARD Q03181 4/20 0.36
PPARG P37231 4/20 0.36
FFAR4 Q5NUL3 1/20 0.35
ITGB7 P26010 2/20 0.35
KCNA3 P22001 2/20 0.35
KIFC1 Q9BW19 1/20 0.34
PSMB5 P28074 2/20 0.34
CAPN1 P07384 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5927084 0.92 KIFC1 (0.41) LRRK2NPC1RAB9AITGA4ITGB1
SCHEMBL5927080 0.92 KIFC1 (0.41) LRRK2NPC1RAB9AITGA4ITGB1
SCHEMBL5927392 0.91 ABCG2 (0.43) LRRK2LMNAPOLBNPSR1ITGA4
SCHEMBL5927387 0.91 ABCG2 (0.43) LRRK2LMNAPOLBNPSR1ITGA4
SCHEMBL8337501 0.88 LRRK2 (0.47) LRRK2LMNAPOLBNPSR1ABCG2
SCHEMBL8337386 0.88 LRRK2 (0.49) LRRK2LMNAPOLBNPSR1ABCG2
SCHEMBL8337545 0.86 LRRK2 (0.38) LRRK2LMNAPOLBNPSR1ITGA4
SCHEMBL8337399 0.85 LRRK2 (0.49) LRRK2POLBITGA4ITGB1ABCG2
SCHEMBL8337866 0.85 PTPN11 (0.44) LRRK2LMNAPOLBNPSR1ITGA4
SCHEMBL8337880 0.83 ITGA4 (0.39) LRRK2LMNAPOLBNPSR1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014844-A2 ARYL AND HETEROARYL COMPOUNDS AND METHODS TO MODULATE COAGULATION TRANSTECH PHARMA, INC. (US) 2004-02-19 WO disclosed